Simon V. van Reijmersdal

2.5k citations

25 papers · 1.1k indexed · h-index 11

Genetics top 5%
Public Health, Environmental and Occupational Health top 5%
Molecular Biology
Hematology top 5%
Pediatrics, Perinatology and Child Health top 5%

Co-authors: Ad Geurts van Kessel Roland P. Kuiper Peter M. Hoogerbrugge Esmé Waanders Frank N. van Leeuwen Joris A. Veltman Eric Schoenmakers Rolph Pfundt
Topics: Acute Lymphoblastic Leukemia research (12 papers)Chronic Myeloid Leukemia Treatments (7 papers)Cancer-related gene regulation (6 papers)
Cited by: Hematology Genetics Pediatrics, Perinatology and Child Health
Journals: Journal of Clinical Oncology Blood PLoS ONE
Partner nations: Netherlands United States Germany

In The Last Decade

Simon V. van Reijmersdal

25 papers receiving 1.1k citations

Peers

Countries citing papers authored by Simon V. van Reijmersdal

Since Specialization

Citations

This map shows the geographic impact of Simon V. van Reijmersdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon V. van Reijmersdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon V. van Reijmersdal more than expected).

Fields of papers citing papers by Simon V. van Reijmersdal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon V. van Reijmersdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon V. van Reijmersdal. The network helps show where Simon V. van Reijmersdal may publish in the future.

Co-authorship network of co-authors of Simon V. van Reijmersdal

This figure shows the co-authorship network connecting the top 25 collaborators of Simon V. van Reijmersdal. A scholar is included among the top collaborators of Simon V. van Reijmersdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon V. van Reijmersdal. Simon V. van Reijmersdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia 2023 ·Cell Reports ·Willem K. Smits,Carlo Vermeulen,(unknown),Shunsuke Kimura,Eric Vroegindeweij,Jessica G. C. A. M. Buijs-Gladdines,(unknown),Marjon J.A.M. Verstegen,Erik Splinter,Simon V. van Reijmersdal,Arjan Buijs,Niels Galjart,(unknown),Max van Min,Roland P. Kuiper,Patrick Kemmeren,Charles G. Mullighan,Wouter de Laat,Jules P.P. Meijerink	5
2	Trio-based whole exome sequencing in patients with suspected sporadic inborn errors of immunity: A retrospective cohort study 2022 ·eLife ·(unknown),Annet Simons,Janneke Schuurs-Hoeijmakers,(unknown),Evelien Zonneveld‐Huijssoon,Stefanie Henriet,Ellen Schatorjé,Esther Hoppenreijs,Erika Leenders,(unknown),Gijs W.E. Santen,Sonja A. de Munnik,Simon V. van Reijmersdal,Esther van Rijssen,Simone Kersten,Mihai G. Netea,Ruben L. Smeets,Frank L. van de Veerdonk,Alexander Hoischen,Caspar I. van der Made	4
3	Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19 2021 ·Frontiers in Immunology ·Xavier Solanich,Gardenia Vargas‐Parra,Caspar I. van der Made,Annet Simons,Janneke Schuurs-Hoeijmakers,Arnau Antolí,Jesús Del Valle,Gemma Rocamora-Blanch,Fernando Setién,Manel Esteller,Simon V. van Reijmersdal,Antoni Riera‐Mestre,Joan Sabater‐Riera,Gabriel Capellá,Frank L. van de Veerdonk,Ben van der Hoven,Xavier Corbella,Alexander Hoischen,Conxi Lázaro	74
4	Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations 2020 ·Haematologica ·Željko Antić,Jiangyan Yu,Simon V. van Reijmersdal,(unknown),(unknown),(unknown),Edwin Sonneveld,Marta Fiocco,Rob Pieters,Peter M. Hoogerbrugge,Frank N. van Leeuwen,Ad Geurts van Kessel,Esmé Waanders,Roland P. Kuiper	14
5	Upfront Treatment Influences the Composition of Genetic Alterations in Relapsed Pediatric B‐Cell Precursor Acute Lymphoblastic Leukemia 2020 ·HemaSphere ·Jiangyan Yu,Esmé Waanders,Simon V. van Reijmersdal,Željko Antić,(unknown),Edwin Sonneveld,(unknown),Marta Fiocco,Ad Geurts van Kessel,Frank N. van Leeuwen,Rob Pieters,Peter M. Hoogerbrugge,Roland P. Kuiper	5
6	Accurate detection of low-level mosaic mutations in pediatric acute lymphoblastic leukemia using single molecule tagging and deep-sequencing 2017 ·Leukemia & lymphoma ·Jiangyan Yu,Željko Antić,Simon V. van Reijmersdal,Alexander Hoischen,Edwin Sonneveld,Esmé Waanders,Roland P. Kuiper	5
7	Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences 2016 ·Leukemia ·Esmé Waanders,Blanca Scheijen,Marjolijn C.J. Jongmans,Hanka Venselaar,Simon V. van Reijmersdal,(unknown),Agata Pastorczak,Robbert D.A. Weren,C. Ellen van der Schoot,(unknown),Edwin Sonneveld,Nicoline Hoogerbrugge,Vincent H. J. van der Velden,Bernd Gruhn,Peter M. Hoogerbrugge,Jacques J. M. van Dongen,Ad Geurts van Kessel,Frank N. van Leeuwen,Roland P. Kuiper	38
8	Targeted Locus Amplification & Next Generation Sequencing for the Detection of Recurrent and Novel Gene Fusions for Improved Treatment Decisions in Pediatric Acute Lymphoblastic Leukemia 2015 ·Blood ·Roland P. Kuiper,Simon V. van Reijmersdal,Marieke Simonis,Jiangyan Yu,Edwin Sonneveld,Blanca Scheijen,Judith M. Boer,Aurélie Boeree,Petra Klous,Peter M. Hoogerbrugge,Mehmet Birhan Yılmaz,Frank N. van Leeuwen,Monique L. den Boer,Erik Splinter	3
9	Correlation of childhood acute lymphoblastic leukemia subclones carrying intragenic IKZF1 deletions with relapse. 2014 ·Journal of Clinical Oncology ·Peter M. Hoogerbrugge,Esmé Waanders,(unknown),Simon V. van Reijmersdal,(unknown),Edwin Sonneveld,Rob Pieters,(unknown),Frank N. van Leeuwen,Roland P. Kuiper	1
10	DNA copy number alterations mark disease progression in paediatric chronic myeloid leukaemia 2014 ·British Journal of Haematology ·(unknown),Manuela Krumbholz,Agata Pastorczak,Blanca Scheijen,Josephine T. Tauer,(unknown),Edwin Sonneveld,Geertruida H. de Bock,(unknown),Simon V. van Reijmersdal,Roland P. Kuiper,Jutta Bradtke,Markus Metzler,Meinolf Suttorp,E. S. J. M. de Bont,Frank N. van Leeuwen	8
11	Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL 2013 ·Blood ·Arian van der Veer,Esmé Waanders,Rob Pieters,Marieke E. Willemse,Simon V. van Reijmersdal,Lisa J. Russell,Christine J. Harrison,William E. Evans,Vincent H. J. van der Velden,Peter M. Hoogerbrugge,Frank N. van Leeuwen,Gabriele Escherich,Martin A. Horstmann,(unknown),Dimitris Rizopoulos,Hester A. de Groot‐Kruseman,Edwin Sonneveld,Roland P. Kuiper,Monique L. den Boer	187
12	The Origin and Nature of Tightly Clustered BTG1 Deletions in Precursor B-Cell Acute Lymphoblastic Leukemia Support a Model of Multiclonal Evolution 2012 ·PLoS Genetics ·Esmé Waanders,Blanca Scheijen,Laurens T. van der Meer,Simon V. van Reijmersdal,Liesbeth van Emst,Yvet Kroeze,Edwin Sonneveld,Peter M. Hoogerbrugge,Ad Geurts van Kessel,Frank N. van Leeuwen,Roland P. Kuiper	59
13	Validation Study of Existing Gene Expression Signatures for Anti-TNF Treatment in Patients with Rheumatoid Arthritis 2012 ·PLoS ONE ·Erik J. M. Toonen,Christian Gilissen,Barbara Franke,Wietske Kievit,A M M Eijsbouts,Alfons A den Broeder,Simon V. van Reijmersdal,Joris A. Veltman,Hans Scheffer,Timothy R. D. J. Radstake,Piet L. C. M. van Riel,Pilar Barrera,Marieke J. H. Coenen	49
14	Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia 2010 ·Leukemia ·Esmé Waanders,Vincent H. J. van der Velden,C. Ellen van der Schoot,Frank N. van Leeuwen,Simon V. van Reijmersdal,Válerie de Haas,A. Veerman,Ad Geurts van Kessel,Peter M. Hoogerbrugge,Roland P. Kuiper,Jacques J. M. van Dongen	91
15	Integrated Use of Minimal Residual Disease Classification and IKZF1 Alteration Status Accurately Predicts 79% of Relapses In Pediatric Acute Lymphoblastic Leukemia 2010 ·Blood ·Esmé Waanders,(unknown),C. Ellen van der Schoot,Frank N. van Leeuwen,Simon V. van Reijmersdal,Válerie de Haas,A. Veerman,Ad Geurts van Kessel,Peter M. Hoogerbrugge,Roland P. Kuiper,Jacques J. M. van Dongen	9
16	High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage 2009 ·Cancer Genetics and Cytogenetics ·Margit Schraders,Simon V. van Reijmersdal,Eveline J. Kamping,J. Han van Krieken,Ad Geurts van Kessel,Patricia J.T.A. Groenen,Peter M. Hoogerbrugge,Roland P. Kuiper	23
17	Deletion of IKZF1 in Pediatric Precursor-B ALL Is a Strong Prognostic Marker for Relapse. 2009 ·Blood ·Roland P. Kuiper,Esmé Waanders,Vincent H. J. van der Velden,Simon V. van Reijmersdal,Blanca Scheijen,Jayne Y. Hehir‐Kwa,(unknown),Edwin Sonneveld,Jacques J. M. van Dongen,Frank N. van Leeuwen,Ad Geurts van Kessel,Peter M. Hoogerbrugge	1
18	Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1 2007 ·Blood ·Jurgen A. Marteijn,Laurens T. van der Meer,Liesbeth van Emst,Simon V. van Reijmersdal,(unknown),Théo de Witte,Joop H. Jansen,Bert A. van der Reijden	28
19	No Evidence For Large-scale Germline Genomic Aberrations in Hereditary Bladder Cancer Patients with High-Resolution Array-Based Comparative Genomic Hybridization 2006 ·Cancer Epidemiology Biomarkers & Prevention ·Lambertus A. Kiemeney,Roland P. Kuiper,Rolph Pfundt,Simon V. van Reijmersdal,Mark Schoenberg,Katja K.H. Aben,Martinus F. Niermeijer,J. Alfred Witjes,Eric Schoenmakers	5
20	Diagnostic Genome Profiling in Mental Retardation 2005 ·The American Journal of Human Genetics ·Bert B.A. de Vries,Rolph Pfundt,M.A.R. Leisink,David A. Koolen,Lisenka E.L.M. Vissers,Irene M. Janssen,Simon V. van Reijmersdal,Willy M. Nillesen,Erik Huys,Nicole de Leeuw,Dominique Smeets,Erik A. Sistermans,Ton Feuth,Conny M.A. van Ravenswaaij‐Arts,Ad Geurts van Kessel,Eric Schoenmakers,Han G. Brunner,Joris A. Veltman	413

About Simon V. van Reijmersdal

Simon V. van Reijmersdal is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Cancer Research, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (12 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Cancer-related gene regulation (6 papers). The work is most often cited by research in Hematology (323 citations), Genetics (434 citations) and Pediatrics, Perinatology and Child Health (297 citations). Simon V. van Reijmersdal has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Ad Geurts van Kessel, Roland P. Kuiper, Peter M. Hoogerbrugge, Esmé Waanders, Frank N. van Leeuwen, Joris A. Veltman, Eric Schoenmakers, Rolph Pfundt, Willy M. Nillesen and David A. Koolen. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact